Sequential chemotherapy (etoposide, vinblastine, and doxorubicin) and subtotal lymph node radiation for patients with localized hodgkin disease and unfavorable prognostic features
Autor: | Chung-Taik Chung, Bruce A. Peterson, George P. Canellos, M. Barcos, Gina R. Petroni, Jeff L. Johnson, Todd H. Wasserman, Frederick E. Millard |
---|---|
Rok vydání: | 1999 |
Předmět: | |
Zdroj: | Cancer. 86:1590-1595 |
ISSN: | 1097-0142 0008-543X |
DOI: | 10.1002/(sici)1097-0142(19991015)86:8<1590::aid-cncr29>3.0.co;2-4 |
Popis: | Division of Oncology, University of Minnesota-Masonic Cancer Center, Minneapolis, Minnesota.Presented in part in abstract form at the AmericanSociety of Clinical Oncology annual meeting, May18–21, 1996 (Proc ASCO1996;15:427).Supported in part by grants CA21060 (C.C.).CA59518 (M.B.), CA32291 (G.P.C.), and CA16450(B.A.P.) from the National Cancer Institute.The research for CALGB 9051 was supported inpart by grants from the National Cancer Institute(research grant CA31946) to the Cancer and Leu-kemia Group B (Richard L. Schilsky, Chairman). Itscontents are solely the responsibility of the authorsand do not necessarily represent the official viewsof the National Cancer Institute.The following institutions participated in the studyand were supported in part by grants from theNational Cancer Institute: CALGB Statistical Office,Durham, NC (Stephen George, Ph.D.; CA33601);Christiana Care Health Services, Inc. CCOP, Wil-mington, DE (Irving M. Berkowitz, D.O.; CA45418);Community Hospital-Syracuse CCOP, Syracuse, NY(Jeffrey Kirshner, M.D.; CA45389); Dana FarberCancer Institute, Boston, MA (CA32291); NorrisCotton Cancer Center, Dartmouth Medical School,Lebanon, NH (L. Herbert Maurer, M.D.; CA04326);Kaiser Permanente CCOP, San Diego, CA(Jonathan A. Polikoff, M.D.; CA45374); Long IslandJewish Medical Center, Lake Success, NY (MarcCitron, M.D.; CA11028); Department of Oncology,McGill University, Montreal, Quebec (Brian Ley-land-Jones, M.D.; CA31809); Mount Sinai Schoolof Medicine, New York, NY (James F. Holland,M.D.; CA04457); North Shore University HospitalCCOP, Manhasset, NY (Vincent Vinciguerra, M.D.;CA35279); Rhode Island Hospital, Providence, RI(Louis A. Leone, M.D.; CA08025); Roswell ParkCancer Institute, Buffalo, NY (Ellis Levine, M.D.;CA02599); Southeast Cancer Control ConsortiumInc. CCOP, Goldsboro, NC (James N. Atkins, M.D.;CA45808); SUNY Health Science Center at Syra-cuse, Syracuse, NY (Stephen L. Graziano, M.D.;CA21060); University of Alabama-Birmingham,Birmingham, AL (Robert Diasio, M.D.; CA47545);University of California at San Diego, San Diego,CA (Stephen L. Seagren, M.D.; CA11789); Univer-sity of Iowa Hospitals, Iowa City, IA (Gerald H.Clamon, M.D.; CA47642); University of Massachu-setts Medical Center, Worcester, MA (Marc Stew-art, M.D.; CA37135); University of Minnesota, Min-neapolis, MN (Bruce A. Peterson, M.D.; CA16450);Wake Forest University School of Medicine, Win-ston-Salem, NC (David D. Hurd, M.D.; CA03927);Walter Reed Army Medical Center, Washington, DC(Nancy A. Dawson, M.D.; CA26806); WashingtonUniversity School of Medicine, St. Louis, MO (Nan-cy L. Bartlett, M.D.; CA77440).George P. Canellos, M.D., is a consultant for Bris-tol-Myers Squibb.Address for reprints: Todd H. Wasserman, M.D.,Professor of Radiation Oncology, Washington Uni-versity Medical Center, 216 South KingshighwayBoulevard, St. Louis, MO 63110.Received November 30, 1998; revision receivedApril 29, 1999; accepted July 15, 1999. |
Databáze: | OpenAIRE |
Externí odkaz: |